Related Experiment Video

Updated: May 22, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Drugs, diagnostic tests approved quickly

Suzanne Rose

    Cancer Discovery
    |May 16, 2012
    PubMed

    Insights

    Accelerated review processes and a deeper understanding of tumor biology are crucial for delivering targeted cancer treatments to patients more quickly. This advancement aims to improve patient outcomes through faster access to innovative therapies.

    Area of Science:

    • Oncology
    • Translational Medicine
    • Drug Development

    Background:

    • Understanding tumor biology is essential for developing effective cancer therapies.
    • Traditional drug development timelines can delay patient access to novel treatments.

    Discussion:

    • Accelerated review pathways can expedite the approval of promising targeted therapies.
    • Enhanced knowledge of tumor-specific molecular targets facilitates precision medicine approaches.

    Key Insights:

    • Faster review and a deeper grasp of tumor biology significantly shorten the time to patient treatment.
    • This synergy between regulatory processes and scientific understanding drives therapeutic innovation.

    Outlook:

    • Continued integration of advanced diagnostics and regulatory science will further optimize treatment delivery.
    • Future research will focus on refining targeted therapies and expanding their application across diverse cancer types.

    More Related Videos

    Rapid Molecular Detection and Differentiation of Influenza Viruses A and B05:38

    Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

    Published on: January 30, 2017

    Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones06:06

    Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

    Published on: February 5, 2018

    Related Concept Videos

    Automated Microbial Diagnostics01:24

    Automated Microbial Diagnostics

    Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
    Therapeutic Drug Monitoring: Drug Analysis Methods01:26

    Therapeutic Drug Monitoring: Drug Analysis Methods

    Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
    Clinical Trials: Overview01:11

    Clinical Trials: Overview

    Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
    FDA Approved Drugs: Changes to Approved Drugs01:26

    FDA Approved Drugs: Changes to Approved Drugs

    Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
    Drug Regulation01:25

    Drug Regulation

    Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
    Drug Administration and Therapy Phases: Overview01:26

    Drug Administration and Therapy Phases: Overview

    Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
    The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
    The pharmacokinetic phase...